CLINICAL_TRIALS
trial_result
· 2006-07-25
Clinical Trial Update: Optimal Length of Treatment Continuation With Olanzapine After Remission of Manic or Mixed Episode [Phase 4]
Summary
This Phase 4 trial evaluated how long to continue olanzapine after remission from manic or mixed episodes in bipolar disorder.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eli Lilly and Company | Conditions: Bipolar Disorder | Phase 4 | Status: COMPLETED